Health ❯ Chronic Diseases

Diabetes

Type 2 Diabetes Obesity Hypertension Risk Factors Treatment Options Type 1 Diabetes Management Heart Disease Complications Cardiovascular Disease

U.S. Obesity Rate Drops as GLP-1 Use Surges, Gallup Finds

High prices, patchy coverage, frequent discontinuation plus side effects threaten to limit any population gains.

New Obesity Criteria Would Classify Nearly 70% of U.S. Adults as Obese, Study Finds

GLP-1 Drugs Tied to Slower Alcohol Absorption and Weaker Intoxication in Virginia Tech Pilot

GLP-1 Drugs Tied to Atypical PET-CT Uptake, Raising Misdiagnosis Risk

Common Genetic Variant Skews HbA1c, Delaying Diabetes Diagnosis in Black and South Asian Men

World Heart Day Spurs Early-Detection Drive as Mexico Reports 210,000 Heart Deaths

Heart Disease Caused One in Three Deaths Worldwide in 2023, Global Report Finds

Cruciferous Vegetables Temper Blood-Sugar Swings in Short Randomized Trial

Year-Long, Very-High-Fat Keto Diet Triggers Metabolic Harm in Mice

USC Study Identifies Top Mortality Risks in MASLD, With Hypertension Leading

Cinnamon In Coffee Linked To Antioxidant Boost And Sharper Memory, New Study Finds

Orforglipron Phase 3 Results Published, Show Promise as Oral GLP-1 Option for Obesity

Triple-Dose Semaglutide Outperforms Standard Regimen in Weight-Loss Trials

Long-Running UK Study Links Planetary Health Diet to Lower Diabetes Risk and Emissions

Large EHR Study Links Cannabis Use to Fourfold Higher Type 2 Diabetes Risk

Obesity’s Toll Mounts in Latin America as Mexico Counts 180 Billion-Peso Burden and Therapies Advance

GLP-1 Debate Intensifies: Australia Considers Subsidies as India Warns of Misuse Risks

Gene-Encoded Peptides Steer Gut Microbes, Modulating Insulin Resistance in Mice

Novo Nordisk to Cut 9,000 Jobs in Global Restructuring

Microbial D‑Lactate Tied to Liver Fat and High Blood Sugar as Mouse ‘Gut Trap’ Shows Benefit